Paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: a phase II clinical trial

Wang, ZQ; Hu, MT; Hu, YH; Li, QQ; Wu, JD; Fong, WP; Ren, C; Wang, DS; Tan, Q; Yang, H; Li, YH

Yang, H; Li, YH (通讯作者)，Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China.;Li, YH (通讯作者)，Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou, Peoples R China.;Yang, H (通讯作者)，Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou, Peoples R China.;Li, YH (通讯作者)，Sun Yat Sen Univ, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, 651 Dong Feng Dong St, Guangzhou 510060, Peoples R China.

ESOPHAGUS, 2022; 19 (1): 120

Abstract

Purpose This phase II trial aimed to assess the safety and efficacy of paclitaxel in combination with cisplatin and 5-fluorouracil (TPF) induction che......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索